Business Context and Reporting Period
This Form 8-K is filed by Cyclacel Pharmaceuticals, Inc. (not Bio Green Med Solution, Inc.) for the reporting period of July 8, 2011. The registrant is incorporated in Delaware and is based in Berkeley Heights, NJ. The filing addresses a material modification to the rights of security holders regarding the Company's 6% Convertible Exchangeable Preferred Stock.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial disclosure relates to the non-payment of a quarterly cash dividend on the Preferred Stock for the second quarter of 2011, which was scheduled to be payable on August 1, 2011.
Material Changes Versus Prior Period
- Dividend Non-Payment: The Board decided not to declare the Q2 2011 dividend. This follows a pattern of non-payment for all four quarters of fiscal year 2009 and the first three quarters of 2010.
- Accrual of Dividends: Unpaid dividends are accrued. The Company has now failed to pay an aggregate amount equal to at least six quarterly dividends.
- Governance Change: Due to the failure to pay six quarterly dividends, the Board size was increased by two members. Holders of the Preferred Stock elected two directors on May 24, 2011, to fill these vacancies.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future operations. The primary risk and contingency identified is the governance structure of the Board. The two directorships held by Preferred Stock holders will terminate only when the Company pays all accrued but unpaid dividends. The filing implies ongoing liquidity constraints preventing dividend payments.
Important Facts for Investor Verification
- Verify the total amount of accrued but unpaid dividends on the 6% Convertible Exchangeable Preferred Stock.
- Confirm the current composition of the Board of Directors, specifically the two directors elected by Preferred Stock holders.
- Review the Company's latest balance sheet to assess liquidity and ability to fund future dividend payments or operations.
- Check for any subsequent filings regarding the payment of accrued dividends or further changes to the Board composition.